Hsiao Lieu
Hoofd Techniek/Wetenschap/O&O bij NGM BIOPHARMACEUTICALS, INC.
Vermogen: 55 499 $ op 31-03-2024
Actieve functies van Hsiao Lieu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2019 | - |
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Loopbaan van Hsiao Lieu
Eerdere bekende functies van Hsiao Lieu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-11-2017 | 01-03-2019 |
| PORTOLA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | 01-01-2008 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | 01-01-2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| Retinorx LLC | Algemeen Directeur | - | - |
| Oprichter | - | - | |
| CAPRICOR THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2008 | - |
Opleiding van Hsiao Lieu
| New York University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 12 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 5 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
| Retinorx LLC | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Hsiao Lieu
- Ervaring
